Bid Publish Date
01-Aug-2026, 6:20 pm
Bid End Date
22-Aug-2026, 7:00 pm
Location
Progress
Organization: Indian Army (Department Of Military Affairs) in POONCH, JAMMU & KASHMIR - 185101. Procurements cover multiple pharmaceutical products under a single tender: Inj Tenecteplase TNK TPA 40 mg, Tab Chlorzoxazone 500 mg plus Diclofenac Sodium 50 mg plus Paracetamol 325 mg, Tab Common Cold (Cetirizine 5-10 mg + Paracetamol 500 mg + Pseudoephedrine 30-60 mg), Tab Leflunomide 20 mg, and Tab Empagliflozin 25 mg. No explicit BOQ quantities or estimated contract value provided; data points suggest a broad-class medical procurement for military medical stocks. The tender appears to emphasize quantity flexibility via option clauses and extended delivery windows, indicating potentially staged or expandable orders. The start/end dates and exact product volumes are not disclosed in the supplied information, requiring bidders to await official bid documents. The unique aspect lies in combining diverse therapeutic categories under one procurement for a defense medical supply chain. This tender mandates adherence to delivery slot strategies and option-based quantity variation at contract award.
Quantity variation up to 25% at contract placement and during currency
Delivery period calculated as (additional quantity/original quantity) × original delivery period with min 30 days
Notices on EMD, payment terms, and delivery deadlines to be confirmed in official documents
Payment terms to be specified in the contract; ensure alignment with delivery milestones and any advance/LC requirements
Delivery period extends from last date of original delivery order; option-based extensions possible with proportional time calculations
Penalties to be defined in the contract; typical LDs for delayed delivery or non-conformance may apply
Experience in supplying pharmaceutical/medical products to government or defense sectors
GST registration and valid pharmaceutical licenses
Financial stability with audited statements for prior years
Quantity
18203
Category
Inj Tenecteplase TNK TPA 40 mg
Bid Type
Two Packet Bid
Bid Validity
180 (Days)
Bid Type
Service
Evaluation
Total value wise evaluation
Inspection Required
No
RA Qualification Rule
H1-Highest Priced Bid Elimination
Tech Clarification Time
2 Days
EMD Required
No
MII Purchase Preference
Yes
MII Preference Band
L1+20%
MSE Purchase Preference
Yes
MSE Preference Band
L1+15%
MSE Exemption/Relaxation
Yes
Startup Exemption/Relaxation
No
Bid Splitting Applied
No
Past Performance
80 %
Arbitration Clause
No
Mediation Clause
No
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
Yes
Item Category
Inj Tenecteplase TNK TPA 40 mg , Tab Chlorzoxazone 500 mg plus Diclofenac Sodium 50 mg plus Paracetamol 325 mg , Tab Common Cold containing Cetrizine 5 to 10 mg plus paracetamol 500 mg plus Pseudoephedrine 30 to 60 mg , Tab Leflunomide 20 mg , Tab Empagliflozin 25 mg
Max Delivery Days
21
Delivery Locations
1
Delivery Cities
Poonch
| Consignee | Address | City | State | Pincode | Quantity | Delivery Days | Additional Requirement |
|---|---|---|---|---|---|---|---|
| - | Poonch | Poonch | - | - | 3 | 21 | - |
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
Inj Tenecteplase TNK TPA 40 mg
Inj Tenecteplase TNK TPA 40 mg
Tab Chlorzoxazone 500 mg plus Diclofenac Sodium 50 mg plus Paracetamol 325 mg
Tab Chlorzoxazone 500 mg plus Diclofenac Sodium 50 mg plus Paracetamol 325 mg
Tab Common Cold containing Cetrizine 5 to 10 mg plus paracetamol 500 mg plus Pseudoephedrine 30 to 60 mg
Tab Common Cold containing Cetrizine 5 to 10 mg plus paracetamol 500 mg plus Pseudoephedrine 30 to 60 mg
Tab Leflunomide 20 mg
Tab Leflunomide 20 mg
Tab Empagliflozin 25 mg
Tab Empagliflozin 25 mg
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Inj Tenecteplase TNK TPA 40 mg | Inj Tenecteplase TNK TPA 40 mg | 3 | vial | 425.consignee | 21 | |
| 2 | Tab Chlorzoxazone 500 mg plus Diclofenac Sodium 50 mg plus Paracetamol 325 mg | Tab Chlorzoxazone 500 mg plus Diclofenac Sodium 50 mg plus Paracetamol 325 mg | 9,000 | nos | 425.consignee | 21 | |
| 3 | Tab Common Cold containing Cetrizine 5 to 10 mg plus paracetamol 500 mg plus Pseudoephedrine 30 to 60 mg | Tab Common Cold containing Cetrizine 5 to 10 mg plus paracetamol 500 mg plus Pseudoephedrine 30 to 60 mg | 9,000 | nos | 425.consignee | 21 | |
| 4 | Tab Leflunomide 20 mg | Tab Leflunomide 20 mg | 100 | nos | 425.consignee | 21 | |
| 5 | Tab Empagliflozin 25 mg | Tab Empagliflozin 25 mg | 100 | nos | 425.consignee | 21 |
GST certificate
PAN card
Experience certificates in pharmaceutical/medical supply
Financial statements for last 2-3 years
EMD/Security deposit documentation (as specified in official tender)
Technical bid documents (product specs, compliance certificates)
OEM authorizations or license to manufacture/import (where applicable)
Key insights about JAMMU AND KASHMIR tender market
Bidders should obtain the official bid documents, submit GST and PAN, provide pharma licenses, and share OEM authorizations if required. Ensure compliance with the 25% quantity variation option and prepare EMD as specified in the official packet. Delivery terms and payment specifics will be clarified in the contract.
Required documents typically include GST certificate, PAN card, experience certificates in medical supplies, financial statements, EMD documentation, technical compliance certificates, and OEM authorizations. Exact list is in the tender packet; ensure all copies are notarized where needed.
The tender covers Inj Tenecteplase TNK TPA 40 mg, Tab Chlorzoxazone 500 mg with Diclofenac 50 mg and Paracetamol 325 mg, Tab Common Cold with Cetirizine 5-10 mg, Paracetamol 500 mg and Pseudoephedrine 30-60 mg, Tab Leflunomide 20 mg, and Tab Empagliflozin 25 mg.
Delivery terms allow a 25% quantity variation at contract placement and during the currency. The new delivery period is calculated by (additional/original) × original period, with a minimum of 30 days; extensions may be approved by the Purchaser within contract limits.
While explicit standards are not listed in the excerpt, bidders should anticipate GMP/Pharmacopoeia compliance and ISI/ISO certifications as typical government requirements; verify in the official bid packet and attach relevant compliance certificates.
Deadline details are not provided in the data excerpt; consult the official tender documents for submission dates, bid opening times, and any pre-bid queries or amendments.
EMD amount and mode (DD/online) are not specified here; the official tender documents will state the exact figure, acceptable payment method, and validity period to ensure bid eligibility.
Obtain OEM authorization documents from the drug manufacturer or authorized distributor, attach current authorization letters, and ensure products are manufactured or distributed under licensed agreements compliant with government procurement norms.